Загрузка...
The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator
Sacubitril/valsartan therapy reduces sudden cardiac death (SCD) among patients with reduced ejection fraction (HFrEF) when compared to guidelines recommended doses of enalapril, however the mechanism is still not clear. There are few, contrasting results about the effect of sacubitril/valsartan on a...
Сохранить в:
| Опубликовано в: : | J Clin Med |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7230317/ https://ncbi.nlm.nih.gov/pubmed/32294983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9041111 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|